Among patients with oncogene-driven advanced NSCLC who were treated with TKIs, ctDNA clearance was associated with improved survival end points.

The DOJ has sent letters to CHEST and other journals asking that editors answer questions about bias and misinformation.

Chang on behalf of 361 Ohio State University Wexner Medical Center faculty and staff We, the undersigned, are OSU ...

Galapagos (Euronext: GLPG) has appointed Henry Gosebruch as chief executive of its upcoming oncology spin-off ... Receive The Pharma Letter daily news bulletin, free forever. Unfettered access to ...

Over my forty years or so in and around dealing rooms and financial markets, I have heard many theories as to how to approach that problem and have settled on a process that has worked for me.